Clinical Trials Logo

Clinical Trial Summary

The aim of the research project is to investigate the uptake of omega-3 fatty acids into the blood plasma through the consumption of the microalgae Phaeodactylum tricornutum (PT) in a human study. In an open, crossover study, the volunteers will receive a drink enriched with the microalgae P. tricornutum or an omega-3 fatty acid preparation or (optionally) pollock for 14 days each. Since the microalgae P. tricornutum is rich in omega-3 fatty acids, the target parameter chosen is the uptake of omega-3 fatty acids in the blood plasma


Clinical Trial Description

A large number of diet-related diseases, such as obesity, are characterized by subclinical inflammation of the body. For this reason, anti-inflammatory foods such as omega-3 fatty acids, which are found in fish and nuts, are used. However, the disadvantage of fish as a resource is its limited availability. Therefore, it is of great interest to provide a resource-saving diet that still supplies us with all macro and micro nutrients. For this reason, microalgae have become the focus of science in recent years. Microalgae not only serve as a source of protein, but also contain a large number of nutrients that could have possible physiological and preventive effects in human nutrition. These include substances from the group of carotenoids and the various polyunsaturated FS found in microalgae. The microalgae PT is rich in omega-3 FS eicosapentaenoic acid (EPA), which is otherwise found mainly in fatty fish, and could therefore be an alternative or vegetarian source of polyunsaturated fatty acids. Previous work by U. Neumann has shown that the microalgae P. tricornutum could be used for human nutrition. No toxic effects could be observed in vivo and the bioavailability of fatty acids and proteins could also be successfully demonstrated. In vitro experiments also showed a more anti-inflammatory, anti-oxidative and anti-proliferative effect on human blood cells. For this reason, a health-promoting effect is also possible in human nutrition, but this must be proven in human studies. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04288544
Study type Interventional
Source University of Hohenheim
Contact
Status Completed
Phase N/A
Start date February 25, 2020
Completion date September 15, 2020

See also
  Status Clinical Trial Phase
Completed NCT00379158 - Comparison of the Efficacy and Acceptability of Three Types of Micronutrient Supplements in Ghana Phase 4
Completed NCT04734938 - The Effect on Micronutrient Status of a Diet of 100% Huel N/A
Active, not recruiting NCT06146452 - Micronutrient Status in Pediatric Palliative Care
Active, not recruiting NCT04564222 - Sustainable Intervention of Supplementation to Improve Kid's Growth Study N/A
Completed NCT00872365 - Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases N/A
Completed NCT01140256 - Longitudinal Zinc Intakes and Exchangeable Zinc Pool Sizes in Breastfed Small for Gestational Age vs Appropriate for Gestational Age Infants in Pakistan N/A
Completed NCT03422809 - Cyclic Variation in Micronutrient Concentrations and Plasma Volume
Completed NCT05857345 - Breastmilk as a Source of Lactocytes